Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

Nature Biotechnology

Volumn 34, Issue 7, 2016, Pages 726-737

  Bock, Christoph ^a,b,c   Halbritter, Florian ^a   Carmona, Francisco J ^d   Tierling, Sascha ^e   Datlinger, Paul ^a   Assenov, Yassen ^f   Berdasco, María ^d   Bergmann, Anke K ^g,h   Booher, Keith ⁱ   Busato, Florence ^j   Campan, Mihaela ^k   Dahl, Christina ^l   Dahmcke, Christina M ^l   Diep, Dinh ^m   Fernández, Agustín F ^n,o,p   Gerhauser, Clarissa ^f   Haake, Andrea ^g   Heilmann, Katharina ^f   Holcomb, Thomas ^q   Hussmann, Dianna ^r   Ito, Mitsuteru ^s   Kläver, Ruth ^t   Kreutz, Martin ^t   Kulis, Marta ^u   Lopez, Virginia ^n,o,p   Nair, Shalima S ^v,w   Paul, Dirk S ^x   Plongthongkum, Nongluk ^m   Qu, Wenjia ^v   Queirós, Ana C ^u   Reinicke, Frank ^t   Sauter, Guido ^y   Schlomm, Thorsten ^y   Statham, Aaron ^v   Stirzaker, Clare ^v,w   Strogantsev, Ruslan ^s   Urdinguio, Rocío G ^n,o,p   Walter, Kimberly ^q   Weichenhan, Dieter ^f   Weisenberger, Daniel J ^k   Beck, Stephan ^x   Clark, Susan J ^v,w   Esteller, Manel ^d,u,z   Ferguson Smith, Anne C ^s   Fraga, Mario F ^n,o,p   Guldberg, Per ^l   Hansen, Lise Lotte ^r   Laird, Peter W ^k,aa   Martín Subero, José I ^u   Nygren, Anders O H ^ab   Peist, Ralf ^t   Plass, Christoph ^f   Shames, David S ^q   Siebert, Reiner ^g,ac   Sun, Xueguang ⁱ   Tost, Jörg ^j   Walter, Jörn ^e   Zhang, Kun ^m   more..

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e SAARLAND UNIVERSITY   (Germany)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY OF KIEL   (Germany)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁱ Zymo Research Corporation   (United States)

^j CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^m UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

ⁿ DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^o CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^p CINN CSIC UNIOVI PA   (Spain)

^q GENENTECH INC   (United States)

^r AARHUS UNIVERSITY   (Denmark)

^s UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^t QIAGEN GMBH   (Germany)

^u UNIVERSITY OF BARCELONA   (Spain)

^v GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^w UNIVERSITY OF NEW SOUTH WALES   (Australia)

^x UNIVERSITY COLLEGE LONDON   (United Kingdom)

^y UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^z INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^aa VAN ANDEL RESEARCH INSTITUTE   (United States)

^ab AGENA BIOSCIENCE   (United States)

^ac UNIVERSITY HOSPITAL ULM   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; BENCHMARKING; BIOMARKERS; DIAGNOSIS; DNA; METHYLATION;

BISULFITE-SEQUENCING; CLINICAL APPLICATION; CLINICAL DIAGNOSTICS; DNA METHYLATION ANALYSIS; DNA METHYLATION PATTERN; QUANTITATIVE COMPARISON; REFERENCE SAMPLES; TECHNOLOGY COMPARISON;

ASSAYS;

BIOLOGICAL MARKER; DNA; DNA METHYLTRANSFERASE; GENETIC MARKER;

AMPLICON BISULFITE SEQUENCING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BISULFITE PYROSEQUENCING; CELL DIFFERENTIATION; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA METHYLATION; DNA METHYLATION ASSAY; EPIGENETICS; GENE LOCUS; GENOMICS; HUMAN; HUMAN CELL; MOUSE; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE STUDY; SEQUENCE ANALYSIS; SYSTEMATIC REVIEW; VALIDATION STUDY; ALGORITHM; CLINICAL TRIAL; EVALUATION STUDY; GENETIC MARKER; GENETICS; HIGH THROUGHPUT SCREENING; HIGH THROUGHPUT SEQUENCING; MULTICENTER STUDY; PROCEDURES; PROMOTER REGION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; DNA; DNA METHYLATION; DNA MODIFICATION METHYLASES; GENETIC MARKERS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIGH-THROUGHPUT SCREENING ASSAYS; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84978435580     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3605     Document Type: Article

References (72)

1. Baylin, S.B. & Jones, P.A. A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer 11, 726-734 (2011).
2. Portela, A. & Esteller, M. Epigenetic modifications and human disease. Nat. Biotechnol. 28, 1057-1068 (2010).
3. Feil, R. & Fraga, M.F. Epigenetics and the environment: emerging patterns and implications. Nat. Rev. Genet. 13, 97-109 (2011).
4. Benayoun, B.A., Pollina, E.A. & Brunet, A. Epigenetic regulation of ageing: linking environmental inputs to genomic stability. Nat. Rev. Mol. Cell Biol. 16, 593-610 (2015).
5. Reik, W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447, 425-432 (2007).
6. Laird, P.W. The power and the promise of DNA methylation markers. Nat. Rev. Cancer 3, 253-266 (2003).
7. Bock, C. Epigenetic biomarker development. Epigenomics 1, 99-110 (2009).
8. Claus, R. et al. Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia. Blood 124, 42-48 (2014).
9. deVos, T. et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin. Chem. 55, 1337-1346 (2009).
10. Ebert, M.P. et al. TFAP2E-DKK4 and chemoresistance in colorectal cancer. N. Engl. J. Med. 366, 44-53 (2012).
11. Fernandez, A.F. et al. A DNA methylation fingerprint of 1628 human samples. Genome Res. 22, 407-419 (2012).
12. Hegi, M.E. et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 997-1003 (2005).
13. Mahon, K.L. et al. & PRIMe consortium. Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer. Br. J. Cancer 111, 1802-1809 (2014).
14. Queirós, A.C. et al. A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact. Leukemia 29, 598-605 (2015).
15. Papageorgiou, E.A. et al. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat. Med. 17, 510-513 (2011).
16. Bock, C. et al. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439-452 (2011).
17. Park, J.L. et al. Identification of body fluid-specific DNA methylation markers for use in forensic science. Forensic Sci. Int. Genet. 13, 147-153 (2014).
18. Yi, S.H., Xu, L.C., Mei, K., Yang, R.Z. & Huang, D.X. Isolation and identification of age-related DNA methylation markers for forensic age-prediction. Forensic Sci. Int. Genet. 11, 117-125 (2014).
19. Bock, C. Analysing and interpreting DNA methylation data. Nat. Rev. Genet. 13, 705-719 (2012).
20. Laird, P.W. Principles and challenges of genomewide DNA methylation analysis. Nat. Rev. Genet. 11, 191-203 (2010).
21. Rakyan, V.K., Down, T.A., Balding, D.J. & Beck, S. Epigenome-wide association studies for common human diseases. Nat. Rev. Genet. 12, 529-541 (2011).
22. Michels, K.B. et al. Recommendations for the design and analysis of epigenome-wide association studies. Nat. Methods 10, 949-955 (2013).
23. Kristensen, L.S. & Hansen, L.L. PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment. Clin. Chem. 55, 1471-1483 (2009).
24. Mikeska, T., Bock, C., Do, H. & Dobrovic, A. DNA methylation biomarkers in cancer: progress towards clinical implementation. Expert Rev. Mol. Diagn. 12, 473-487 (2012).
25. Umer, M. & Herceg, Z. Deciphering the epigenetic code: an overview of DNA methylation analysis methods. Antioxid. Redox Signal. 18, 1972-1986 (2013).
26. Adams, D. et al. BLUEPRINT to decode the epigenetic signature written in blood. Nat. Biotechnol. 30, 224-226 (2012).
27. Satterlee, J.S., Schübeler, D. & Ng, H.H. Tackling the epigenome: challenges and opportunities for collaboration. Nat. Biotechnol. 28, 1039-1044 (2010).
28. Beck, S. Taking the measure of the methylome. Nat. Biotechnol. 28, 1026-1028 (2010).
29. Bock, C. et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat. Biotechnol. 28, 1106-1114 (2010).
30. Harris, R.A. et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat. Biotechnol. 28, 1097-1105 (2010).
31. Gries, J. et al. Bi-PROF: bisulfite profiling of target regions using 454 GS FLX Titanium technology. Epigenetics 8, 765-771 (2013).
32. Masser, D.R., Berg, A.S. & Freeman, W.M. Focused, high accuracy 5-methylcytosine quantitation with base resolution by benchtop next-generation sequencing. Epigenetics Chromatin 6, 33 (2013).
33. Varley, K.E. & Mitra, R.D. Bisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samples. Genome Res. 20, 1279-1287 (2010).
34. Diep, D. et al. Library-free methylation sequencing with bisulfite padlock probes. Nat. Methods 9, 270-272 (2012).
35. Paul, D.S. et al. Assessment of RainDrop BS-seq as a method for large-scale, targeted bisulfite sequencing. Epigenetics 9, 678-684 (2014).
36. Coolen, M.W., Statham, A.L., Gardiner-Garden, M. & Clark, S.J. Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res. 35, e119 (2007).
37. Ehrich, M. et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl. Acad. Sci. USA 102, 15785-15790 (2005).
38. Ehrich, M. et al. Cytosine methylation profiling of cancer cell lines. Proc. Natl. Acad. Sci. USA 105, 4844-4849 (2008).
39. Ronaghi, M., Uhlén, M. & Nyrén, P. A sequencing method based on real-time pyrophosphate. Science 281, 363-365 (1998).
40. Tost, J., Dunker, J. & Gut, I.G. Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. Biotechniques 35, 152-156 (2003).
41. Tost, J. & Gut, I.G. DNA methylation analysis by pyrosequencing. Nat. Protoc. 2, 2265-2275 (2007).
42. Campan, M., Weisenberger, D.J., Trinh, B. & Laird, P.W. Methy Light. Methods Mol. Biol. 507, 325-337 (2009).
43. Eads, C.A. et al. Methy Light: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28, E32 (2000).
44. Guldberg, P., Worm, J. & Grønbaek, K. Profiling DNA methylation by melting analysis. Methods 27, 121-127 (2002).
45. Wojdacz, T.K., Dobrovic, A. & Hansen, L.L. Methylation-sensitive high-resolution melting. Nat. Protoc. 3, 1903-1908 (2008).
46. Worm, J., Aggerholm, A. & Guldberg, P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin. Chem. 47, 1183-1189 (2001).
47. Herman, J.G., Graff, J.R., Myöhänen, S., Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821-9826 (1996).
48. Walter, K. et al. DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer. Clin. Cancer Res. 18, 2360-2373 (2012).
49. Ehrlich, M. DNA hypomethylation in cancer cells. Epigenomics 1, 239-259 (2009).
50. Aparicio, A. et al. LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors. Epigenetics 4, 176-184 (2009).
51. Berdasco, M., Fraga, M.F. & Esteller, M. Quantification of global DNA methylation by capillary electrophoresis and mass spectrometry. Methods Mol. Biol. 507, 23-34 (2009).
52. Kremer, D., Metzger, S., Kolb-Bachofen, V. & Kremer, D. Quantitative measurement of genome-wide DNA methylation by a reliable and cost-efficient enzyme-linked immunosorbent assay technique. Anal. Biochem. 422, 74-78 (2012).
53. Bollati, V. et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 67, 876-880 (2007).
54. Choi, S.H. et al. Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer. Int. J. Cancer 125, 723-729 (2009).
55. Martínez, J.G. et al. Hypomethylation of LINE-1, and not centromeric SAT-α, is associated with centromeric instability in head and neck squamous cell carcinoma. Cell Oncol. (Dordr.) 35, 259-267 (2012).
56. Yang, A.S. et al. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res. 32, e38 (2004).
57. Shanmuganathan, R. et al. Conventional and nanotechniques for DNA methylation profiling. J. Mol. Diagn. 15, 17-26 (2013).
58. Bibikova, M. et al. Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics 1, 177-200 (2009).
59. Clark, S.J., Harrison, J., Paul, C.L. & Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22, 2990-2997 (1994).
60. Clark, S.J., Statham, A., Stirzaker, C., Molloy, P.L. & Frommer, M. DNA methylation: bisulphite modification and analysis. Nat. Protoc. 1, 2353-2364 (2006).
61. Booth, M.J. et al. Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine. Nat. Protoc. 8, 1841-1851 (2013).
62. Lu, X. et al. Chemical modification-assisted bisulfite sequencing (CAB-Seq) for 5-carboxylcytosine detection in DNA. J. Am. Chem. Soc. 135, 9315-9317 (2013).
63. Song, C.X. et al. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 153, 678-691 (2013).
64. Mikeska, T., Candiloro, I.L. & Dobrovic, A. The implications of heterogeneous DNA methylation for the accurate quantification of methylation. Epigenomics 2, 561-573 (2010).
65. Koeffler, H.P. & Golde, D.W. Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 200, 1153-1154 (1978).
66. Koeffler, H.P., Billing, R., Lusis, A.J., Sparkes, R. & Golde, D.W. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 56, 265-273 (1980).
67. Assenov, Y. et al. Comprehensive analysis of DNA methylation data with RnBeads. Nat. Methods 11, 1138-1140 (2014).
68. Heyn, H. & Esteller, M. DNA methylation profiling in the clinic: applications and challenges. Nat. Rev. Genet. 13, 679-692 (2012).
69. Gentleman, R. & Temple Lang, D. Statistical analyses and reproducible research. Bioconductor project working papers. Working paper 2. http://biostats.bepress.com/bioconductor/paper2##(2004).
70. Holmes, E.E. et al. Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine. PLoS One 9, e93933 (2014).
71. Sing, T., Sander, O., Beerenwinkel, N. & Lengauer, T. ROCR: visualizing classifier performance in R. Bioinformatics 21, 3940-3941 (2005).
72. Chang, Y.-W. & Lin, C.-J. Feature ranking using linear SVM. JMLR Workshop Conf. Proc. 3, 53-64 (2008).